We are monitoring the impact of COVID-19 & Recession alarm on North America Flow Cytometry Market Get in touch with us for detailed analysis Know More
Share on

North America Flow Cytometry Market Research Report – Segmented By Technology, Product, Application, End-users & Country (the United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2022 to 2027)

Published: January, 2022
ID: 2105
Pages: 140

North America Flow Cytometry Market Size (2022 to 2027)

The Flow Cytometry Market size in North America has been estimated at USD 1552.41 Million in 2022 and will worth USD 2511.56 Million by 2027 at a CAGR of 10.1% during the forecast period. In North America, the United States is dominating the market.

The North America Flow Cytometry Market is primarily stimulated by technological progress and high adoption in various research and diagnostic applications. Besides, the increasing incidence rates of diseases such as cancer and HIV are expected to stimulate flow cytometric technology in diagnostic applications. The rising economy in developed countries like the U.S and others is likely to fuel the growth rate of the market. The rise in the elderly population is enhancing the growth rate of the market. 

However, the shortage of skilled technicians in monitoring the systems is slowly restraining the market demand. Also, government bodies' stringent rules and regulations for approvals inhibit the growth rate of the North America Flow Cytometry Market. 

This research report on the North America Flow Cytometry Market has been segmented and sub-segmented into the following categories:

By Technology: 

  • Cell-based
  • Bead-based

By Product: 

  • Reagents & Consumables
  • Flow Cytometry Instruments

By Application: 

  • Research
  • Clinical
  • Industrial

By End-users: 

  • Commercial Organizations
  • Research Institutes
  • Clinical Testing Labs

By Country: 

  • The U.S.
  • Canada
  • Rest of North America

Regionally, North America is the biggest market in terms of market share globally, followed by Europe. The market in North America is majorly driven due to factors such as increasing application of flow cytometry techniques in cancer research, increasing adoption of low cost and compact flow cytometers in clinical diagnostics and research laboratories, and growing infrastructure quality laboratory and clinical research.

The flow cytometry market in North America was dominating the global market. It accounted for a market share of 39.8% in 2019 due to the favorable government reforms for developing advanced technologies in molecular diagnostics, growing awareness among the people, and availability of expert professionals. Also, increasing full applications relevant for flow cytometry methods for different cancer research activities and increasing obtainment of low cost accelerates this region's growth. The growth is also due to the increase in the enlargement of new products, which produces opportunities in the analysis period.

The U.S. flow cytometry market is expected to account for the largest market share in the North American market. The high occurrence rate of various cancers such as breast cancer, lung cancer, prostate cancer, colon and rectum, skin and bladder cancer, and other chronic diseases is majorly attributing the market growth in the United States. The existence of many clinical research labs and many pharmaceutical industries boost up the development of this region. In this country, the growing number of cancer cases, which in turn creates more demand for the flow cytometry market in this region.

The Canadian flow cytometry market is predicted to be held as the second-largest share in the flow cytometry market during the analysis period as there are high research and development activities in this country, the growing occurrence rate of cancer and HIV. The Canadian market is expected to have a colossal healthcare industry; key players concentrate more on inventing and launching new products and devices into the market, fueling the growth.

Companies playing a dominant role in the North America Flow Cytometry Market profiled in this report are Becton, Dickinson and Company, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Life Technologies Corporation Inc., EMD Millipore Corporation, Miltenyi Biotec, Thermo Fischer Scientific, Agilent Technologies, Inc. and Affymetix Inc.

In September 2017, Beckman Coulter, Inc. (United States) released its first CytoFLEX LX flow cytometry for cancer researchers, which has the visible spectrum in a standard configuration. This launch allowed the development of its activity in flow cytometry.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Technology                 

                                5.1.1 Introduction           

                                5.1.2 Cell-based               

                                5.1.3 Bead-based            

                                5.1.4  Y-o-Y Growth Analysis, By Technology       

                                5.1.5  Market Attractiveness Analysis, By Technology     

                                5.1.6  Market Share Analysis, By Technology       

                5.2 Product                        

                                5.2.1 Introduction           

                                5.2.2 Reagents & Consumables 

                                5.2.3 Flow Cytometry Instruments          

                                                5.2.3.1 Cell Analyzers

                                                5.2.3.2 Cell Sorters

                                5.2.5  Y-o-Y Growth Analysis, By Product              

                                5.2.6  Market Attractiveness Analysis, By Product            

                                5.2.7  Market Share Analysis, By Product              

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Research Applications        

                                                5.3.2.1 Pharmaceutical & Biotechnology

                                                5.3.2.2 Immunology

                                                5.3.2.3 Apoptosis

                                                5.3.2.4 Cell Cycle Analysis

                                                5.3.2.5 Cell Sorting

                                                5.3.2.6 Cell Viability

                                                5.3.2.7 Other Research Applications

                                5.3.3 Clinical Applications             

                                                5.3.3.1 Cancer

                                                5.3.3.2 Immunodeficiency Diseases

                                                5.3.3.3 Hematology

                                                5.3.3.4 Organ Transplantation

                                                5.3.3.5 Other Clinical Applications

                                5.3.4 Industrial Applications        

                                5.3.7  Y-o-Y Growth Analysis, By Application        

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.3 End-users                    

                                5.3.1 Introduction           

                                5.3.2 Commercial Organizations

                                5.3.3 Hospitals  

                                5.3.4  Academic Institutions & Medical Schools  

                                5.3.5  Clinical Testing Labs            

                                5.3.6  Research Institutes            

                                5.3.7  Y-o-Y Growth Analysis, By End-users          

                                5.3.8  Market Attractiveness Analysis, By End-users        

                                5.3.9  Market Share Analysis, By End-users          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Technology

                                                6.1.3.3 By Product

                                                6.1.3.4 By Application

                                                6.1.3.5 By End-users

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Technology

                                                6.1.4.3 By Product

                                                6.1.4.4 By Application

                                                6.1.4.5 By End-users

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Technology

                                                6.1.5.3 By Product

                                                6.1.5.4 By Application

                                                6.1.5.5 By End-users

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Becton, Dickinson and Company                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Beckman Coulter, Inc.                            

                8.3 Thermo Fisher Scientific, Inc.                              

                8.4 Merck KGaA                               

                8.5 Sysmex Partec GmbH                            

                8.6 Luminex Corporation                             

                8.7 Miltenyi Biotec GmbH                            

                8.8 Bio-Rad Laboratories, Inc.                    

                8.9 Sony Biotechnology                

                8.10 Life Technologies Corporation Inc.                 

                8.11 EMD Millipore Corporation                

                8.12 Miltenyi Biotec                       

                8.13 Thermo Fischer Scientific                   

                8.14 Agilent Technologies, Inc.                  

                8.15 Affymetix Inc.                         

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Flow Cytometry Market By Technology, From 2021to 2027 (USD Million)
  2. North America Cell-based Market By Region, From 2021to 2027 (USD Million)
  3. North America Bead-based Market By Region, From 2021to 2027 (USD Million)
  4. North America Flow Cytometry Market By Product, From 2021to 2027 (USD Million)
  5. North America Reagents & Consumables Market By Region, From 2021to 2027 (USD Million)
  6. North America Flow Cytometry Instruments Market By Region, From 2021to 2027 (USD Million)
  7. North America Flow Cytometry Market By Application, From 2021to 2027 (USD Million)
  8. North America Research Applications Market By Region, From 2021to 2027 (USD Million)
  9. North America Clinical Applications Market By Region, From 2021to 2027 (USD Million)
  10. North America Industrial Applications Market By Region, From 2021to 2027 (USD Million)
  11. North America Flow Cytometry Market By End-users, From 2021to 2027 (USD Million)
  12. North America Commercial Organizations Market By Region, From 2021to 2027 (USD Million)
  13. North America Hospitals Market By Region, From 2021to 2027 (USD Million)
  14. North America Academic Institutions & Medical Schools Market By Region, From 2021to 2027 (USD Million)
  15. North America Clinical Testing Labs Market By Region, From 2021to 2027 (USD Million)
  16. North America Research Institutes Market By Region, From 2021to 2027 (USD Million)
  17. United States Flow Cytometry Market By Technology, From 2021to 2027 (USD Million)
  18. United States Flow Cytometry Market By Product, From 2021to 2027 (USD Million)
  19. United States Flow Cytometry Market By Application, From 2021to 2027 (USD Million)
  20. United States Flow Cytometry Market By End-users, From 2021to 2027 (USD Million)
  21. Canada Flow Cytometry Market By Technology, From 2021to 2027 (USD Million)
  22. Canada Flow Cytometry Market By Product, From 2021to 2027 (USD Million)
  23. Canada Flow Cytometry Market By Application, From 2021to 2027 (USD Million)
  24. Canada Flow Cytometry Market By End-users, From 2021to 2027 (USD Million)
  25. North America Flow Cytometry Instruments Market By Flow Cytometry Instruments, From 2021to 2027 (USD Million)
  26. North America Cell Analyzers Market By Region, From 2021to 2027 (USD Million)
  27. North America Cell Sorters Market By Region, From 2021to 2027 (USD Million)
  28. United States Flow Cytometry Instruments Market By Flow Cytometry Instruments, From 2021to 2027 (USD Million)
  29. Canada Flow Cytometry Instruments Market By Flow Cytometry Instruments, From 2021to 2027 (USD Million)
  30. North America Research Applications Market By Research Applications, From 2021to 2027 (USD Million)
  31. North America Pharmaceutical & Biotechnology Market By Region, From 2021to 2027 (USD Million)
  32. North America Immunology Market By Region, From 2021to 2027 (USD Million)
  33. North America Apoptosis Market By Region, From 2021to 2027 (USD Million)
  34. North America Cell Cycle Analysis Market By Region, From 2021to 2027 (USD Million)
  35. North America Cell Sorting Market By Region, From 2021to 2027 (USD Million)
  36. North America Cell Viability Market By Region, From 2021to 2027 (USD Million)
  37. United States Research Applications Market By Research Applications, From 2021to 2027 (USD Million)
  38. Canada Research Applications Market By Research Applications, From 2021to 2027 (USD Million)
  39. North America Clinical Applications Market By Clinical Applications, From 2021to 2027 (USD Million)
  40. North America Cancer Market By Region, From 2021to 2027 (USD Million)
  41. North America Immunodeficiency Diseases Market By Region, From 2021to 2027 (USD Million)
  42. North America Hematology Market By Region, From 2021to 2027 (USD Million)
  43. North America Organ Transplantation Market By Region, From 2021to 2027 (USD Million)
  44. North America Other Clinical Applications Market By Region, From 2021to 2027 (USD Million)
  45. United States Clinical Applications Market By Clinical Applications, From 2021to 2027 (USD Million)
  46. Canada Clinical Applications Market By Clinical Applications, From 2021to 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample